Triethylene Glycol

Triethylene Glycol

SCHEMBL1612917

CCC(=O)Oc1cc(C)c(O)c(C(C)(C)C)c1.CCC(=O)Oc1cc(C)c(O)c(C(C)(C)C)c1.OCCOCCOCCO

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VCAM1 P19320 10/20 0.40
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
ACHE P22303 2/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
GAA P10253 1/20 0.34
XBP1 P17861 1/20 0.34
ATM Q13315 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
RECQL P46063 2/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
ESR1 P03372 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HIF1A Q16665 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29732475 0.89 CYP1A2 (0.47) VCAM1CYP1A2CYP2C9CYP2C19ACHE
SCHEMBL716507 0.89 CYP1A2 (0.47) VCAM1CYP1A2CYP2C9CYP2C19ACHE
Triethylene Glycol SCHEMBL29282748 0.84 ATM (0.50) ACHEGAAXBP1ATMNPSR1
SCHEMBL27505106 0.83 CYP1A2 (0.41) VCAM1CYP1A2CYP2C9CYP2C19ACHE
SCHEMBL1007367 0.83 VCAM1 (0.40) VCAM1CYP1A2CYP2C9CYP2C19CA1
Ethylene Glycol SCHEMBL3760959 0.82 VCAM1 (0.51) VCAM1CA1CA2GAARECQL
SCHEMBL9863033 0.82 VCAM1 (0.38) VCAM1CYP1A2CYP2C9CYP2C19CA1
SCHEMBL100583 0.81 CA2 (0.53) VCAM1CA1CA2GAARECQL
Methane SCHEMBL4563808 0.79 CA2 (0.52) VCAM1CA1CA2GAARECQL
SCHEMBL30999666 0.79 CA2 (0.52) VCAM1CA1CA2GAARECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9133121-B2 Weakly basic hindered amines compounds having carbonate skeletons, synthetic resin compositions and coating compositions NEGISHI YOSHINORI (JP) 2015-09-15 US claimed
US-20250129206-A1 POLYESTER-BASED PLASTICIZER, VINYL CHLORIDE-BASED RESIN COMPOSITION CONTAINING SAME, AND MOLDED ARTICLE THEREOF ADEKA CORPORATION (JP) 2025-04-24 US disclosed
US-10784417-B2 Wavelength conversion film FUJIFILM CORPORATION (JP) 2020-09-22 US disclosed
US-20190348578-A1 WAVELENGTH CONVERSION FILM FUJIFILM CORPORATION (JP) 2019-11-14 US disclosed
US-20190345357-A1 WAVELENGTH CONVERSION FILM FUJIFILM CORPORATION (JP) 2019-11-14 US disclosed
US-10274782-B2 Backlight unit, liquid crystal display device, and wavelength conversion member FUJIFILM CORPORATION (JP) 2019-04-30 US disclosed
EP-3222693-B1 ULTRAVIOLET ABSORBER AND SYNTHETIC RESIN COMPOSITION ADEKA CORP (JP) 2019-04-17 EP disclosed
EP-3037480-B1 POLYPHENYLENE SULFIDE RESIN COMPOSITION, AND MOULDING AND MANUFACTURING PROCESS FOR MOULDING THEREOF TORAY INDUSTRIES (JP) 2019-02-20 EP disclosed
US-10144814-B2 Ultraviolet absorber and synthetic resin composition ADEKA CORPORATION (JP) 2018-12-04 US disclosed
US-20170233551-A1 ULTRAVIOLET ABSORBER AND SYNTHETIC RESIN COMPOSITION ADEKA CORPORATION (JP) 2017-08-17 US disclosed
EP-2676997-A1 VINYL CHLORIDE RESIN COMPOSITION Adeka Corporation (JP) 2013-12-25 EP disclosed
US-20130317157-A1 VINYL CHLORIDE RESIN COMPOSITION ADEKA CORPORATION (JP) 2013-11-28 US disclosed
EP-2554591-A1 TRANSPARENTIZATION AGENT COMPOSITION CONTAINING SORBITOL COMPOUND AND METHOD FOR PRODUCING POLYPROPYLENE RESIN COMPOSITION USING THIS SORBITOL COMPOUND Adeka Corporation (JP) 2013-02-06 EP disclosed
EP-1731508-B1 WEAKLY BASIC HINDERED AMINES HAVING CARBONATE SKELETONS, SYNTHETIC RESIN COMPOSITIONS, AND COATING COMPOSITIONS ADEKA CORP (JP) 2012-08-01 EP disclosed
US-20110087023-A1 METHOD FOR PRODUCING 2,4,6-TRIS(HYDROXYPHENYL)-1,3,5-TRIAZINE COMPOUND ADEKA CORPORATION (JP) 2011-04-14 US disclosed
US-20100305327-A1 NITROXYL COMPOUND, AND POLYMERIZATION INHIBITOR AND POLYMERIZATION INHIBITOR COMPOSITION USING SAME ADEKA CORPORATION (JP) 2010-12-02 US disclosed
US-20090111699-A1 Weakly Basic Hindered Amines Having Carbonate Skeletons, Synthetic Resin Compositions, And Coating Compositions ADEKA CORPORATION (JP) 2009-04-30 US disclosed
EP-1978017-A1 NITROXYL COMPOUND, AND POLYMERIZATION INHIBITOR AND POLYMERIZATION INHIBITOR COMPOSITION USING SAME Adeka Corporation (JP) 2008-10-08 EP disclosed
EP-1731508-A1 WEAKLY BASIC HINDERED AMINES HAVING CARBONATE SKELETONS, SYNTHETIC RESIN COMPOSITIONS, AND COATING COMPOSITIONS Adeka Corporation (JP) 2006-12-13 EP disclosed
EP-1156083-A1 RESIN COMPOSITION FOR AGRICULTURAL FILM ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) 2001-11-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10144814-B2 Ultraviolet absorber and synthetic resin composition RER1, XRCC5, REV1 VCAM1 2785/4885CYP1A2 582/4885CYP2C9 2004/4885
US-20090111699-A1 Weakly Basic Hindered Amines Having Carbonate Skeletons, Synthetic Resin Compositions, And Coating Compositions H1-2, H1-3, H1-4 VCAM1 1343/4885CYP1A2 2896/4885CYP2C9 3712/4885
US-20170233551-A1 ULTRAVIOLET ABSORBER AND SYNTHETIC RESIN COMPOSITION RER1, XRCC5, REV1 VCAM1 2785/4885CYP1A2 582/4885CYP2C9 2004/4885
US-20100305327-A1 NITROXYL COMPOUND, AND POLYMERIZATION INHIBITOR AND POLYMERIZATION INHIBITOR COMPOSITION USING SAME NOX5, NOX1, NOC2L VCAM1 1553/4885CYP1A2 1023/4885CYP2C9 872/4885
US-20110087023-A1 METHOD FOR PRODUCING 2,4,6-TRIS(HYDROXYPHENYL)-1,3,5-TRIAZINE COMPOUND QSOX1, TST, TH VCAM1 4061/4885CYP1A2 255/4885CYP2C9 1316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.